ARHI

What ARHI does

ARHI is a privately held for-profit company headquartered in Naples, Florida, that operates in the medical research sector with a stated specialization in clinical research and health improvement. The firm was founded in 2017 and employs between 11 and 50 people, placing it in the small-business tier of the clinical research services market. Its public-facing web property (arhiusa.com) returned only a loader/verification page at the time of data collection, yielding no extractable detail on service lines, therapeutic areas, trial phases supported, sponsors served, or technology platform.

The underlying business model, pricing mechanics, customer mix, go-to-market approach, and product portfolio cannot be characterized from the available data. No funding rounds, investor disclosures, partnership announcements, leadership bios, or regulatory actions were surfaced. As a result, the revenue model — whether fee-for-service clinical operations, consulting, site management, or research support — is not determinable from the input. The lack of disclosed financials, customers, or partnerships represents a meaningful diligence gap rather than a confirmed business profile.

For an investment audience, ARHI presents as an early-stage, sub-scale clinical research entity with limited public footprint. Without product-level evidence, named customers, or capital formation signals, any investment thesis would require primary diligence on service capabilities, sponsor pipeline, regulatory credentials (e.g., IRB relationships, GCP compliance), and revenue quality. The current data set supports only a baseline fact base and does not warrant directional conclusions about competitiveness, growth, or capital efficiency.

Name

ARHI

Website

https://arhiusa.com

Company type

Private

Founded year

2017

Headcount range

1–10 employees

Short description

ARHI is a privately held Naples, Florida-based medical research firm founded in 2017, employing 11–50 people and specializing in clinical research and health improvement services. Its specific service offerings, customers, and technology stack are not disclosed in available data.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)

Keywords

• Clinical research services
• Medical research
• Health improvement research
• Clinical trials
• Healthcare research

Headquarters

HQ city

Naples

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Core offering

ARHI operates in the medical research industry, focusing on clinical research and health improvement. The company provides research services within the healthcare and life sciences domain, supporting studies aimed at advancing clinical knowledge and patient health outcomes.

Product overview

ARHI (arhiusa.com) - Unable to extract product information. The source data consisted only of a website loading/verification page ("One moment, please...") with no substantive content about products, services, or company offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Medpace: Medpace is a mid-sized, full-service clinical research organization specializing in Phase II/III clinical development for small and mid-sized biopharma sponsors. It is one of the most directly comparable CROs to ARHI given its pure-play clinical research focus and US roots.
• Clinipace Worldwide: Clinipace is a smaller, privately held CRO offering clinical research services to emerging and mid-sized biopharma sponsors. As a small/mid-market private clinical research services provider, it is a directly comparable peer to ARHI in scale and customer profile.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO focused on clinical development across multiple therapeutic areas. As a privately held CRO of similar mid-market profile, it is a directly comparable peer to a small, private clinical research company like ARHI.

Broad incumbents

• Thermo Fisher Scientific (PPD): Through its PPD Clinical Research Services business, Thermo Fisher offers end-to-end clinical research services from early development through post-approval. It serves the same sponsor customer base as ARHI and represents the broader incumbent competitive set.
• ICON plc: ICON is a leading global CRO offering clinical development, consulting, and commercial services across all phases of research. It competes with ARHI for outsourced clinical research work from the same sponsor base, with substantially broader capabilities.
• IQVIA: IQVIA is the world's largest contract research organization, providing clinical research and broader life sciences services to pharma and biotech sponsors. It is comparable to ARHI as a broad incumbent operating in the same clinical research services space, although at vastly greater scale.
• Parexel: Parexel is a global CRO providing clinical research, regulatory, and consulting services to biopharma. As a private, larger clinical research services provider, it is comparable to ARHI's clinical research orientation and to the broader competitive environment ARHI operates in.
• Charles River Laboratories: Charles River provides research models, discovery, and clinical research services to biopharma. It is comparable to ARHI as an incumbent CRO/research services provider, though with significantly broader and more capital-intensive capabilities.
• SGS Health Sciences (clinical research): SGS provides clinical research and bioanalytical services as part of its broader testing, inspection, and certification portfolio. It is comparable to ARHI as an incumbent offering clinical research services to pharma and biotech sponsors.
• Labcorp (incl. Covance/Fortrea): Labcorp's clinical development and central laboratory services (with Fortrea spun out as a standalone CRO) address the same clinical research outsourcing market as ARHI. They are direct incumbents in clinical research services at much larger scale.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights3 records

Customer concentration

• Xx.com/arhiusa
• Facebookfacebook.com/ARHIusa
• LinkedInlinkedin.com/company/advanced-research-for-health-improvement

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ARHI